Mark Yarmarkovich, Phd Email and Phone Number
Mark Yarmarkovich, Phd work email
- Valid
Mark Yarmarkovich, Phd personal email
Generating immunotherapies for cancer patients in need. Developed novel therapies from target discovery to clinical trial. Working at the intersection of cancer biology, biotechnology, computational biology, immunology towards development of personalized medicine in oncology.
Nyu Langone Health
View- Website:
- nyulangone.org
- Employees:
- 14440
-
Principal Investigator And Assistant ProfessorNyu Langone HealthNew York, Ny, Us -
Principal Investigator & Assistant ProfessorNyu Langone Health Jan 2023 - PresentNew York, New York, United States -
Senior ScientistChildren'S Hospital Of Philadelphia Aug 2021 - Present -
Postdoctoral ScientistChildren'S Hospital Of Philadelphia Aug 2019 - Aug 2021Philadelphia -
FounderTantigen Bio Feb 2021 - PresentPhiladelphia, Pennsylvania, United States -
Scientific Co-FounderHula Therapeutics Sep 2020 - Present -
PhdUniversity Of Pennsylvania School Of Medicine Sep 2012 - Jun 2019PhiladelphiaThesis project: Tumor target discovery and T-cell engineering. -
Research AssociateGenentech Aug 2010 - Apr 2012South San FranciscoWorked in the antibody-drug conjugate (ADC) group to develop novel delivery systems for potent therapeutic agents used in oncology. -
Associate EngineerGenentech Aug 2008 - Aug 2010South San FranciscoCompleted a two-year rotational program consisting of four projects in departments across Genentech in process research & development. -
FounderWiscolinks May 2006 - Jan 2010Created website used by over 10,000 UW-Madison students per day as a portal for localized information involving student interests and necessities.
-
Biomedical EngineerHarvard Medical School Feb 2008 - Aug 2008Worked on improving and implementing a 3D tracking system combining ultrasound and MRI images used for procedures in pancreatic cancer. -
Research InternGenentech Jun 2007 - Aug 2007Studied the effects of PI3K pathway inhibitors on Breast Cancer Resistance Protein (BCRP) efflux pump function. Identified compounds capable of suppressing BCRP multi-drug resistance pump mechanism by targetting the PI3K enzyme also associated with cancer proliferation. -
Research AssistantHoward Hughes Medical Institute Aug 2006 - May 2007Worked on studying interactions between virus and host cells. Studied effects of silencing of various host cell genes on virus replication.
Mark Yarmarkovich, Phd Skills
Mark Yarmarkovich, Phd Education Details
-
Cell And Molecular Biology - Cancer -
Biochemistry And Molecular Biology -
Biomedical Engineering, Pre-Med
Frequently Asked Questions about Mark Yarmarkovich, Phd
What company does Mark Yarmarkovich, Phd work for?
Mark Yarmarkovich, Phd works for Nyu Langone Health
What is Mark Yarmarkovich, Phd's role at the current company?
Mark Yarmarkovich, Phd's current role is Principal Investigator and Assistant Professor.
What is Mark Yarmarkovich, Phd's email address?
Mark Yarmarkovich, Phd's email address is my****@****hop.edu
What schools did Mark Yarmarkovich, Phd attend?
Mark Yarmarkovich, Phd attended University Of Pennsylvania School Of Medicine, University Of California, Berkeley, University Of Wisconsin-Madison.
What skills is Mark Yarmarkovich, Phd known for?
Mark Yarmarkovich, Phd has skills like Laboratory, Chromatography, Cell Biology, Elisa, Western Blotting, Hplc, Proteomics, Genomics, Antibodies, Cancer Genomics, Data Analysis, Assay Development.
Who are Mark Yarmarkovich, Phd's colleagues?
Mark Yarmarkovich, Phd's colleagues are Jennifer Yanes, Sydney V, Franny Valdez, Cheryl Zhang, Md, Evelyn Millan, Elizabeth Quilty, Greg Sweeney.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial